Analyst Insights

Maxim Keeps ‘Buy’ On Stem Cells Following Interim Phase I/II Trial Data

In a research note issued today, Maxim Group analyst Jason Kolbert reiterated coverage with a “Buy” rating on StemCells Inc. (STEM), and a price target of $2.

Roth Capital Maintains Neutral On Diamondback Energy, Increases PT To $91

In a research note issued today, Roth Capital analyst Joseph Reagor maintained a Neutral rating on Diamondback Energy, Inc. (FANG) and raised his price target to $91.

Roth Capital Maintains Buy On Golden Minerals, Increases Price Target To $1.20

In a research note issued today, Roth Capital analyst Joseph Reagor maintained a Buy rating on Golden Minerals Company (AUMN) and raised his price target to …

Roth Capital Reiterates Buy On Summer Infant, Boosts Price Target To $3.50

Roth Capital recently hosted investor meetings with Summer Infant’s (SUMR) management and came away highly impressed by new CEO Carol Bramson’s strategic vision …

Roth Capital Reiterates Buy On Crown Crafts Following 4QFY14 Earnings

In a research note released this morning, Roth Capital analyst Dave King reiterated coverage with a “Buy” rating on Crown Crafts, Inc. (CRWS), and a price target of $9.

H.C. Wainwright Reiterates Buy On OncoSec Following YTD Results

In a research note issued this morning, H.C.

Roth Capital Reiterates Buy On Derma Sciences Following Analyst Day;Revising Estimates

In a research note released this morning, Roth Capital analyst Scott Henry reiterated coverage with a “Buy” rating on Derma Sciences Inc. (DSCI) and …

H.C. Wainwright Reiterates Buy On Insmed Incorporated, $30 PT

In a research note released today, H.C.

Maxim Reiterates ‘Buy’ On Inovio Pharmaceuticals, Adjusts Price Target

In a report published today, Maxim analyst Jason Kolbert reiterated a Buy rating on Inovio Pharmaceuticals, Inc. (INO) with an adjusted price target of $18.

Wedbush Maintains Bearish Stance on EnerNOC

Wedbush analyst Craig Irwin today maintained an “Underperform” rating on EnerNOC, Inc. (ENOC) with $9.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts